Moderate to Severe Ulcerative Colitis
You may qualify to participate in a clinical research study with an investigational drug for individuals with Moderate to Severe Ulcerative Colitis.
• At least 18 years of age
• Have a documented diagnosis of moderate to severe Ulcerative Colitis ≥ 4 months prior
• Have failed or be intolerant of at least one of the following treatments for UC:
o Oral corticosteroids
o Azathioprine or 6-mercaptopurine (6-MP)
o Anti-TNF therapy: infliximab or adalimumab
• If taking the one of the following medication, are on a stable dose:
o Oral 5-ASA or sulfasalazine stable dose for at least 4 weeks prior to start of study drug and during study period
o Oral corticosteroids (prednisone equivalent up to 25mg/day; budesonide up to 9 mg/day) stable dose for at least 2 weeks prior to start of study drug and during study period
o Chronic treatment for ulcerative colitis with antibiotics (eg, metronidazole, rifaximim) stable dose for at least 2 weeks prior to start of study drug and during study period.
Qualified participants will receive at no cost:
• Study-related medical exams and follow-ups
• Laboratory testing
• Study medication
FOR MORE INFORMATION, PLEASE CONTACT:
Advanced Gastroenterology Associates, LLC
Research Department
34041 US Highway 19, North, Suite A
Palm Harbor, FL 34684
727-216-0768 Direct Line
727-786-7521 Fax
[email protected] email
All medical information is strictly confidential
